RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
DarioHealth Stock

DarioHealth Revenue 2024

DarioHealth Revenue

27.76 M USD

Ticker

DRIO

ISIN

US23725P2092

WKN

A2PU1R

In 2024, DarioHealth's sales reached 27.76 M USD, a 36.4% difference from the 20.35 M USD sales recorded in the previous year.

The DarioHealth Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2028e--
2027e--
2026e--
2025e--
2024e--
2023--
2022--
2021--
2020--
2019--
2018--
2017--
2016--
2015--
2014--
2013--
2012--
2011--

DarioHealth Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into DarioHealth, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by DarioHealth from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects DarioHealth’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of DarioHealth. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into DarioHealth’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing DarioHealth’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on DarioHealth’s growth potential.

DarioHealth Revenue, EBIT and net profit per share

DateDarioHealth RevenueDarioHealth EBITDarioHealth Net Income
2028e0 undefined0 undefined0 undefined
2027e0 undefined0 undefined0 undefined
2026e0 undefined0 undefined0 undefined
2025e0 undefined0 undefined0 undefined
2024e0 undefined0 undefined0 undefined
20230 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined

DarioHealth stock margins

The DarioHealth margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DarioHealth. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DarioHealth.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the DarioHealth's sales revenue. A higher gross margin percentage indicates that the DarioHealth retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the DarioHealth's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the DarioHealth's total revenue generated. When comparing the revenue margin year over year, investors can gauge the DarioHealth's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the DarioHealth. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the DarioHealth's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

DarioHealth Margin History

DarioHealth Gross marginDarioHealth Profit marginDarioHealth EBIT marginDarioHealth Profit margin
2028e0 %0 %0 %
2027e0 %0 %0 %
2026e0 %0 %0 %
2025e0 %0 %0 %
2024e0 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %
20110 %0 %0 %

DarioHealth Aktienanalyse

What does DarioHealth do?

DarioHealth Corp specializes in digital health solutions. It was founded in 2011 and is based in New York, USA. It was founded by Dror Bacher and Oren Fuerst with the goal of helping people with diabetes live healthier lives. They developed a mobile app that allows people with diabetes to monitor their blood sugar levels and improve their health. The company's business model focuses on developing and selling digital health solutions for people with diabetes and other chronic conditions. They work with insurance companies and healthcare providers to sell their products and services to patients. The company is divided into different divisions that cater to the needs of diabetes patients and people with chronic conditions. These divisions include the DarioHealth app, DarioEngage, DarioHealth for Employers, and DarioHealth for Pharma. The company offers a range of products including the DarioHealth Smart Meter, DarioHealth Smart Insulin Pen, and DarioHealth Smart CGM. Overall, DarioHealth Corp is an innovative company that offers tailored digital health solutions for people with diabetes and other chronic conditions. DarioHealth ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding DarioHealth's Sales Figures

The sales figures of DarioHealth originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing DarioHealth’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize DarioHealth's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in DarioHealth’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about DarioHealth stock

How much revenue did DarioHealth generate this year?

DarioHealth has achieved a revenue of 27.76 M USD this year.

How much was the turnover of the company DarioHealth compared to the previous year?

The revenue of DarioHealth has increased by 36.4% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of DarioHealth?

The revenue of DarioHealth is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of DarioHealth measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of DarioHealth so important for investors?

The revenue of DarioHealth is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does DarioHealth pay?

Over the past 12 months, DarioHealth paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, DarioHealth is expected to pay a dividend of 0 USD.

What is the dividend yield of DarioHealth?

The current dividend yield of DarioHealth is .

When does DarioHealth pay dividends?

DarioHealth pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of DarioHealth?

DarioHealth paid dividends every year for the past 0 years.

What is the dividend of DarioHealth?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is DarioHealth located?

DarioHealth is assigned to the 'Health' sector.

Wann musste ich die Aktien von DarioHealth kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of DarioHealth from 10/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/24/2024.

When did DarioHealth pay the last dividend?

The last dividend was paid out on 10/24/2024.

What was the dividend of DarioHealth in the year 2023?

In the year 2023, DarioHealth distributed 0 USD as dividends.

In which currency does DarioHealth pay out the dividend?

The dividends of DarioHealth are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von DarioHealth

Our stock analysis for DarioHealth Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DarioHealth Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.